Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia
暂无分享,去创建一个
Gabriela Alexe | Tobias Berg | Hanibal Bohnenberger | Henning Urlaub | Tim Beissbarth | Federico Comoglio | Carsten Müller-Tidow | Astrid Wachter | Hubert Serve | Kimberly Stegmaier | Timm Schroeder | Michael A. Rieger | Lars Palmqvist | T. Beißbarth | K. Stegmaier | A. Green | G. Alexe | F. Kuchenbauer | T. Schroeder | H. Urlaub | R. Humphries | L. Palmqvist | H. Serve | C. Müller-Tidow | F. Comoglio | H. Bohnenberger | H. Bönig | E. Schütz | M. Rieger | C. Doebele | T. Oellerich | P. Ströbel | F. Schnütgen | A. Rouhi | J. Beck | Frank Schnütgen | Sebastian Mohr | Carmen Doebele | Julia Beck | Jasmin Corso | Philipp Ströbel | Anjali Cremer | Nadine Haetscher | Stefanie Göllner | Arefeh Rouhi | Halvard Bönig | Florian Kuchenbauer | Ekkehard Schütz | Anthony R. Green | R. Keith Humphries | Thomas Oellerich | H. Bonig | T. Berg | J. Corso | S. Göllner | Anjali Cremer | N. Haetscher | A. Wachter | Sebastian Mohr | T. Beissbarth | Nadine Haetscher
[1] G. Wang,et al. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. , 2005, Blood.
[2] A. Wan,et al. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. , 2006, Blood.
[3] E. Kjeldsen,et al. The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML , 2009, European journal of haematology.
[4] Wolfram Goessling,et al. The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML , 2010, Science.
[5] M. Heuser,et al. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3. , 2008, Experimental hematology.
[6] R. Humphries,et al. Hox genes in hematopoiesis and leukemogenesis , 2007, Oncogene.
[7] K. Takeshita,et al. MEIS1 and HOXA7 genes in human acute myeloid leukemia. , 2000, Leukemia research.
[8] M. Miller,et al. Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion , 2016, PloS one.
[9] K. Ross,et al. SYK Regulates mTOR Signaling in AML , 2013, Leukemia.
[10] F. Rosenbauer,et al. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. , 2011, Blood.
[11] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[12] M. Mann,et al. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.
[13] M. Cleary,et al. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. , 2007, Genes & development.
[14] L. Kömüves,et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias , 1999, Leukemia.
[15] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[16] Raphael Gottardo,et al. Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.
[17] M. Słabicki,et al. Elucidation of tonic and activated B-cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival , 2016, Proceedings of the National Academy of Sciences.
[18] G. Sauvageau,et al. Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions. , 2007, Experimental hematology.
[19] L. Lanier,et al. Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone , 2005, Immunological reviews.
[20] G. Wang,et al. Persistent Transactivation by Meis1 Replaces Hox Function in Myeloid Leukemogenesis Models: Evidence for Co-Occupancy of Meis1-Pbx and Hox-Pbx Complexes on Promoters of Leukemia-Associated Genes , 2006, Molecular and Cellular Biology.
[21] A. Baron,et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia , 2002, Leukemia.
[22] Christof Fellmann,et al. An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.
[23] H. Urlaub,et al. β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. , 2013, Blood.
[24] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[25] P. Linsley,et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.
[26] H. Urlaub,et al. FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation. , 2015, Blood.
[27] U. Thorsteinsdóttir,et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. , 1995, Genes & development.
[28] U. Thorsteinsdóttir,et al. marrow cells induces stem cell expansion gene in bone Hoxa 9 associated − Overexpression of the myeloid leukemia , 2001 .
[29] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[30] G. Boucher,et al. RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity. , 2011, Blood.
[31] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[32] J. Aster,et al. SYK is a critical regulator of FLT3 in acute myeloid leukemia. , 2014, Cancer cell.
[33] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[34] J. Hess,et al. The pathogenesis of mixed-lineage leukemia. , 2012, Annual review of pathology.
[35] Michael Reth,et al. Autoinhibition and adapter function of Syk , 2009, Immunological reviews.
[36] E. Marcotte,et al. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.
[37] Piotr J. Balwierz,et al. ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs , 2014, Genome research.
[38] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[39] S. Wingert,et al. STAT5-regulated microRNA-193b controls haematopoietic stem and progenitor cell expansion by modulating cytokine receptor signalling , 2015, Nature Communications.
[40] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[41] A. Verma,et al. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia , 2015, Nature Medicine.
[42] A. Plückthun,et al. Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment , 2016, PLoS pathogens.
[43] K. Stegmaier,et al. Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia , 2015, Oncotarget.
[44] C. Bloomfield,et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] P. Roepstorff,et al. Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns* , 2005, Molecular & Cellular Proteomics.
[46] M. Selbach,et al. Global quantification of mammalian gene expression control , 2011, Nature.
[47] M. Heuser,et al. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3. , 2010, Blood.
[48] Tina N. Davis,et al. Proteomic and genetic approaches identify Syk as an AML target. , 2009, Cancer cell.
[49] Peter F. Stadler,et al. ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology.
[50] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[51] Philipp S. Hoppe,et al. Hematopoietic Cytokines Can Instruct Lineage Choice , 2009, Science.
[52] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[53] J. Kutok,et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1 , 2004, Nature Genetics.
[54] Ryan D. Morin,et al. Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.
[55] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[56] Malachi Griffith,et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model. , 2008, Genome research.
[57] S. Lowe,et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.
[58] G. Nolan,et al. Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML. , 2012, Cell stem cell.
[59] Scott A. Armstrong,et al. MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.
[60] Ryan D. Morin,et al. Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. , 2011, Blood.
[61] G. Boucher,et al. The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias , 2015, Nature Genetics.
[62] M. Heuser,et al. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. , 2009, Blood.
[63] G. Sauvageau,et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] C. Buske,et al. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. , 2003, Blood.
[65] J. Rush,et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.
[66] M. Nóbrega,et al. PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway , 2014, Leukemia.
[67] R. Humphries,et al. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells , 1999, Leukemia.
[68] Unnur Thorsteinsdottir,et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.
[69] C. Lavau,et al. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation. , 2007, Blood.
[70] A. Schambach,et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. , 2007, Blood.
[71] K. Akashi,et al. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells , 2015, Cancer science.
[72] A. Hero,et al. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. , 2012, Blood.
[73] Nicola K. Wilson,et al. Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. , 2011, Cancer cell.
[74] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[75] R. Humphries,et al. Differential and Common Leukemogenic Potentials of Multiple NUP98-Hox Fusion Proteins Alone or with Meis1 , 2004, Molecular and Cellular Biology.
[76] R. Humphries,et al. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. , 2002, Experimental hematology.
[77] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.
[78] F. Rosenbauer,et al. Effect of transcription-factor concentrations on leukemic stem cells. , 2005, Blood.
[79] M. Mann,et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.
[80] Fatima Al-Shahrour,et al. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. , 2013, Cancer cell.
[81] M. Mann,et al. Quantitative Phosphoproteomics Applied to the Yeast Pheromone Signaling Pathway*S , 2005, Molecular & Cellular Proteomics.
[82] R. Humphries,et al. Transplantable cell lines generated with NUP98–Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA , 2005, Leukemia.